510(k) K260026 ยท NQD Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Tina-quant Cardiac high sensitivity CRP III
| Applicant | Roche Diagnostics, Indianapolis IN, US |
| Decision | Substantially Equivalent, Apr 2, 2026 |
| Received | Jan 5, 2026 |
| Type | Traditional |
| FDA record | Open on fda.gov |
Recalls that name K260026
No recall in the FDA data names this 510(k).
Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.